BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 8967154)

  • 1. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H; Kieser M; Hölscher U
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
    Schweizer J; Hautmann C
    Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination.
    Mouren X; Caillard P; Schwartz F
    Angiology; 1994 Jun; 45(6):413-7. PubMed ID: 8203766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease.
    Wang J; Zhou S; Bronks R; Graham J; Myers S
    Clin Rehabil; 2007 Jul; 21(7):579-86. PubMed ID: 17702699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Cochrane library: Ginkgo biloba for intermittent claudication.
    Nicolaï SP; Gerardu VC; Kruidenier LM; Prins MH; Teijink JA
    Vasa; 2010 May; 39(2):153-8. PubMed ID: 20464671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of Gingkco Biloba Extract in patients with intermittent claudication.
    Thomson GJ; Vohra RK; Carr MH; Walker MG
    Int Angiol; 1990; 9(2):75-8. PubMed ID: 2254678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gingko biloba extract EGb 761 and pentoxifylline in intermittent claudication. Secondary analysis of the clinical effectiveness].
    Letzel H; Schoop W
    Vasa; 1992; 21(4):403-10. PubMed ID: 1485476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.
    Horsch S; Walther C
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):63-72. PubMed ID: 15180165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
    JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.
    Maurer K; Ihl R; Dierks T; Frölich L
    J Psychiatr Res; 1997; 31(6):645-55. PubMed ID: 9447569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.
    Pittler MH; Ernst E
    Am J Med; 2000 Mar; 108(4):276-81. PubMed ID: 11014719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba for intermittent claudication.
    Nicolaï SP; Kruidenier LM; Bendermacher BL; Prins MH; Teijink JA
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006888. PubMed ID: 19370657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ginkgo biloba (EGb 761) on treadmill walking time among adults with peripheral artery disease: a randomized clinical trial.
    Gardner CD; Taylor-Piliae RE; Kiazand A; Nicholus J; Rigby AJ; Farquhar JW
    J Cardiopulm Rehabil Prev; 2008; 28(4):258-65. PubMed ID: 18628657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No significant effect of ginkgo biloba special extract EGb 761 in the treatment of primary Raynaud phenomenon: a randomized controlled trial.
    Bredie SJ; Jong MC
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):215-21. PubMed ID: 22030896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.